Continuous Flow N-Demethylation of Morphinan Alkaloids
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional batch reactors are poorly suited for the catalytic oxidative N-demethylation of morphinan alkaloids due to safety risks and inefficiencies in mass and heat transport, particularly when using oxygen gas as an oxidant, which can lead to irreversible decomposition and explosion hazards.
Innovation Solution
A continuous flow system utilizing a palladium catalyst and molecular oxygen as the oxidant for N-demethylation of morphinan alkaloids, allowing for safe and controlled reactions under high temperature/high pressure conditions, reducing waste generation, and improving reaction kinetics.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional batch reactors are used for catalytic oxidative N-demethylation with oxygen gas, then the reaction can be performed, but safety risks (explosion hazards) and inefficiencies in mass and heat transport occur
Solution Approach 1:
The patent replaces conventional batch mechanical stirring and heating systems with a continuous flow reactor system that uses controlled fluid dynamics for mass and heat transport. The flow system enables precise control of reaction conditions while eliminating safety hazards associated with batch processing of oxygen gas, thereby improving both safety and reaction efficiency simultaneously
Solution Approach 2:
The patent changes the operational parameters from batch mode to continuous flow mode, enabling controlled delivery of oxygen gas at optimized flow rates. This parameter change allows the reaction to proceed efficiently while maintaining safe operating conditions through continuous monitoring and control, resolving the contradiction between safety and productivity
2Productivity
If conventional batch reactors are used, then the reaction can proceed, but mass transfer effects dominate and adversely affect reaction kinetics and selectivity
Solution Approach 1:
The patent replaces conventional batch mixing mechanisms with a continuous flow system that provides superior mass and heat transfer characteristics. The flow reactor design eliminates dominant mass transfer limitations present in batch systems, enabling the reaction to proceed under kinetic control with improved selectivity and reaction rates
Solution Approach 2:
The patent introduces dynamic control of flow rates and residence times in the continuous flow system. This dynamic adjustment allows optimization of mass transfer conditions to match reaction kinetics requirements, thereby improving both reaction productivity and manufacturing precision/selectivity simultaneously
3Ease of manufacture
If stoichiometric amounts of toxic reagents (cyanogen bromide, chloroformates) are used for N-demethylation, then the reaction can be achieved, but highly toxic and corrosive reagents are used and stoichiometric amounts of waste products are generated
Solution Approach 1:
The patent employs controlled oxidation using oxygen gas as the terminal oxidant in the N-demethylation reaction. This approach replaces stoichiometric toxic reagents with a benign oxidant, enabling the reaction to proceed feasibly while generating minimal harmful waste, thus resolving the contradiction between ease of manufacture and environmental harm
Solution Approach 2:
The patent eliminates the need to handle and dispose of stoichiometric amounts of toxic reagent waste by using oxygen gas that produces water as the primary byproduct. This approach discards the harmful waste generation step entirely while maintaining reaction feasibility through the catalytic oxidative pathway
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The continuous flow system enables efficient and safe N-demethylation of morphinan alkaloids, reducing explosion risks and hazardous waste while maintaining high selectivity and yield, making it suitable for industrial-scale production.
Implementation Method 1
A continuous flow system utilizing a palladium catalyst and molecular oxygen as the oxidant for N-demethylation of morphinan alkaloids
Implementation Method 2
catalytic oxidative N-demethylation of morphinan alkaloids
Implementation Method 3
The present disclosure addresses these concerns by using a continuous process having high mass and heat transport capabilities
Implementation Method 4
Gaseous reagents can be easily and accurately added and mixed into the liquid phase using flow-based systems. Importantly, combustion and explosion hazards are reduced because gaseous reagents can be dissolved in flammable organic solvents at high pressure
Data Source
AI summary
The present disclosure relates to N-demethylation of a compound containing a tertiary N-methylamine, including for example a morphinan alkaloid, in a continuous flow system. In particular, the present disclosure relates to N-demethylation of oxymorphone-3,14-diacetate or 14-hydroxymorphinone-3,14-diacetate using highly active catalytic palladium (0) in a continuous flow system under elevated temperature and pressure condition. The methodology can be utilized towards the synthesis of noroxymorphone via aerobic palladium-catalyzed continuous flow N-demethylation.